[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
Risk Assessments for Registered Pharmacies Providing Pharmacy Services at a Distance

Risk Assessments for Registered Pharmacies Providing Pharmacy Services at a Distance

by Steven Hewison | Apr 9, 2025 | Blog, Pharmacy

Risk Assessments are a regulatory requirement in medicines wholesaling but have you considered that they could also be very useful in pharmacy practice?

New Best practice guidance on the sale of medicines for pain relief

New Best practice guidance on the sale of medicines for pain relief

by Steven Hewison | Apr 2, 2025 | Blog, MHRA, Pharmacy Suppliers

The MHRA have updated their Blue Guide on Advertising and Promoting Medicines. The update is to Appendix 4 with new Best Practice guidance on the sale of medicines for pain relief.

The Windsor Framework Part 3

The Windsor Framework Part 3

by Steven Hewison | Aug 29, 2024 | Blog, MHRA, Windsor Framework

Unless they appear on the NIMAR list, PLGB licensed medicines are not licensed in Northern Ireland. That means they are effectively supplied to NI as an Unlicensed ‘Special’.

The Windsor Framework Part 3

The Windsor Framework Part 2

by Steven Hewison | Aug 28, 2024 | Blog, MHRA, Windsor Framework

After the implementation of the Windsor Framework, the Medicines and Healthcare products Regulatory Agency (MHRA) will license all medicines across the whole of the UK’.

The Windsor Framework Part 3

The Windsor Framework Part 1 (recap)

by Steven Hewison | Aug 27, 2024 | Blog, MHRA, Windsor Framework

From the 1st of January 2025 the supply of medicines to Northern Ireland will be governed by the Windsor Framework, which will replace the Northern Ireland Protocol.

« Older Entries
Next Entries »

Recent Posts

  • UK Confirms Indefinite Recognition of CE-Marked Medical Devices
  • Minister responsible for Pharmacy announced
  • Heatwaves, Medicines and the Leadership Imperative

Upcoming Courses

  • GDP/RP Cogent Gold Standard Online Training on 17 November 2026
  • Superintendent Pharmacist training (Online) on 25 November 2026
  • RP Forum – tbc on 1 December 2026 10:00 am
  • GDP Audit Online Training on 7 December 2026 10:00 am
  • Introduction to Good Distribution Practice Online Training on 8 December 2026 10:00 am

MHRA Alerts & Recalls

Class 4 Medicines Defect Notification: Star Pharmaceuticals Ltd, Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets, EL(26)A/48
12 November 2026
Field Safety Notices from 02 to 06 November2026.
10 November 2026
Class 4 Medicines Defect Notification: Sandoz Limited, Co-Amoxiclav powder for oral suspension 250/62.5 mg/5mL, EL(26)A/46
5 November 2026
Class 3 Medicines Recall: Aspire Pharma Limited, Tropicamide 1% Eye Drops, solution in single dose containers 20 x 0.5ml , EL(26)A/47
5 November 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow